• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Publishers > GBI Research
Publisher
Filter

GBI Research Report List

GBI Research provides industry-leading global business intelligence solutions. Our products and services help companies make better business decisions, win business and position themselves more effectively. GBI Research publishes more than 100 research reports per annum across a wide range of industries. Our reports draw on in-depth primary and secondary research, databases of proprietary in-house data and high quality analysis from our expert teams. GBI Research employs hundreds of highly qualified Analysts across the US, Europe and Asia. Key report types currently published by GBI Research include: ? Market Intelligence Reports: premium analytical reports based on a combination of market data, company, deals and project content, industry surveys and additional primary and secondary research. ? Benchmarking Reports: analytical reports comparing key financial indicators for the top 20 companies in a particular industry and geography. ? Industry Outlook Reports: survey-based reports, revealing and analyzing the leading experts' opinions on the future of the industry covered. ? Market Profiles: overview-level reports based on market, company and demographic data. ? Pipeline Analysis Reports: reports analyzing the unmet need, market size and product pipeline for different disease indications, based on a detailed database of developmental products.

Filter
Title Search
1 - 25 of 124 Products Sort by Display
Osteoporosis Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by ongoing Transition from Anti-resorptive Agents to Anabolic Therapies, Rising Prevalence, and Growing Awareness
Published by
GBI Research
Product code
366603
Published
July 1, 2018
Content info
138 Pages
Price
USD 4995
Sample available
Menopausal Disorders Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
659303
Published
June 29, 2018
Content info
84 Pages
Price
USD 3995
Sample available
Diabetes and Associated Metabolic Conditions Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
659302
Published
June 29, 2018
Content info
344 Pages
Price
USD 3995
Sample available
Hepatitis Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
537171
Published
June 29, 2018
Content info
133 Pages
Price
USD 3995
Sample available
Psoriasis Therapeutics in Asia-Pacific Markets to 2024 - Increasing Prevalence, Advent of Novel Biologics and Pipeline Drugs to Drive the Market
Published by
GBI Research
Product code
651709
Published
June 1, 2018
Content info
125 Pages
Price
USD 4995
Sample available
Mosquito-borne Diseases Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
648603
Published
May 24, 2018
Content info
142 Pages
Price
USD 3995
Sample available
Ocular Cancer Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
648604
Published
May 23, 2018
Content info
63 Pages
Price
USD 3995
Sample available
Inflammatory Skin Diseases Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
648602
Published
May 22, 2018
Content info
112 Pages
Price
USD 3995
Sample available
Frontier Pharma: Schizophrenia - Diverse First-in-Class Pipeline Shows Promise for Treatment of Negative and Cognitive Symptoms
Published by
GBI Research
Product code
648605
Published
May 1, 2018
Content info
68 Pages
Price
USD 6995
Sample available
Breast Cancer Therapeutics in Asia-Pacific Markets to 2024 - Growth Driven by Increasing Uptake of Targeted Therapies and Rising Prevalence
Published by
GBI Research
Product code
353594
Published
May 1, 2018
Content info
215 Pages
Price
USD 4995
Sample available
Respiratory Syncytial Virus and Human Parainfluenza Virus 3 Infections Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
633179
Published
April 30, 2018
Content info
82 Pages
Price
USD 3995
Sample available
Influenza A Viral Infections Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
633178
Published
April 30, 2018
Content info
188 Pages
Price
USD 3995
Sample available
Frontier Pharma: Type 2 Diabetes Mellitus - Therapies Targeting GPCRs and Protein Kinases Dominate Pipeline, with Strong Repositioning Opportunities into Associated Areas, Including Obesity and Cardiovascular Disease
Published by
GBI Research
Product code
630781
Published
April 1, 2018
Content info
77 Pages
Price
USD 6995
Sample available
Cognitive Impairment Disorders Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
630779
Published
April 1, 2018
Content info
376 Pages
Price
USD 3995
Sample available
HAE Therapeutics in Asia-Pacific Markets to 2023 - Growth Driven by Ongoing Shift towards Plasma-Derivative Products and Expected Launch of Premium Therapies
Published by
GBI Research
Product code
633177
Published
March 31, 2018
Content info
92 Pages
Price
USD 4995
Sample available
Global Immunology Drugs Market to 2023 - Shifting Landscape as Uptake of Interleukin Receptor Inhibitors Offsets Losses for Top Blockbuster Drugs
Published by
GBI Research
Product code
516017
Published
March 31, 2018
Content info
181 Pages
Price
USD 4995
Sample available
Fungal Foot Infections Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
622433
Published
March 22, 2018
Content info
58 Pages
Price
USD 3995
Sample available
Non Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) Drug Development Pipeline Review, 2018
Published by
GBI Research
Product code
622432
Published
March 22, 2018
Content info
159 Pages
Price
USD 3995
Sample available
Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2023 - Novel JAK and IL-6 Receptor Inhibitors to Stimulate Moderate Growth Despite Launch of Biosimilars of Blockbuster Anti-TNFs
Published by
GBI Research
Product code
622434
Published
March 1, 2018
Content info
148 Pages
Price
USD 4995
Sample available
Global Neurodegenerative Diseases Drugs Market to 2023 - MS Set to Dominate with Tecfidera and Ocrevus, as Disease-Modifying Pipeline Therapies for Alzheimer's Disease and SMA Show Clinical and Commercial Potential
Published by
GBI Research
Product code
614183
Published
February 7, 2018
Content info
199 Pages
Price
USD 4995
Sample available
Uveitis Therapeutics in Asia-Pacific Markets to 2023 - Increasing Prevalence, Continued Uptake of Biologics and Novel Pipeline Drugs to Drive the Market
Published by
GBI Research
Product code
611856
Published
February 1, 2018
Content info
91 Pages
Price
USD 4995
Sample available
Frontier Pharma: Women's Health - An Expanding Therapy Area, with Endometriosis Therapies Prominent among the First-in-Class Pipeline
Published by
GBI Research
Product code
611855
Published
February 1, 2018
Content info
86 Pages
Price
USD 6995
Sample available
Antibacterial Therapeutics - High levels of Pipeline Innovation Focused on the Increasing Unmet Need Associated with Antibiotic Resistance
Published by
GBI Research
Product code
604380
Published
January 1, 2018
Content info
73 Pages
Price
USD 6995
Sample available
Head and Neck Cancer Therapeutics in Asia-Pacific Markets to 2023 - Launch of Premium Immunotherapies and Increasing Prevalence to Drive the Market
Published by
GBI Research
Product code
630780
Published
December 27, 2017
Content info
155 Pages
Price
USD 4995
Sample available
Lower Female Reproductive System Cancers Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
601161
Published
December 26, 2017
Content info
129 Pages
Price
USD 3995
Sample available